|
|
 Previous Article | Table of Contents | Next Article 
Effect of inflammatory cytokines on hypoxia-induced erythropoietin
production
WC Faquin, TJ Schneider and MA Goldberg
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.
The effects of the inflammatory cytokines interleukin-1 alpha (IL-1 alpha),
IL-1 beta, IL-6, transforming growth factor-beta (TGF-beta), and tumor
necrosis factor-alpha (TNF-alpha) on erythropoietin (Epo) production in
Hep3B cells were examined. The addition of IL-1 alpha, IL- 1 beta, or
TNF-alpha resulted in a dose-dependent inhibition of hypoxia- induced Epo
production by as much as 89%. IL-1 beta was the most effective cytokine
tested, demonstrating half-maximal inhibition at 0.4 U/mL compared with 1.0
and 10.0 U/mL for IL-1 alpha and TNF-alpha, respectively. TGF-beta also
inhibited hypoxia-induced Epo production, but only by as much as 56%. In
contrast to IL-1 alpha, IL-1 beta, TNF- alpha, and TGF-beta, the addition
of IL-6 to hypoxic Hep3B cells resulted in a dose-dependent stimulation of
hypoxia-induced Epo production by as much as 81%. However, IL-6 did not
stimulate Epo synthesis in the absence of hypoxia, and was thus synergistic
with hypoxia in inducing Epo production. Combinations of IL-1 alpha, TNF-
alpha, and IL-6 were found to be additive in their effects on hypoxia-
induced Epo production. By Northern blot analysis, Epo messenger RNA levels
in Hep3B cells grown in 1% O2 were decreased when concurrently exposed to
either IL-1 alpha or TNF-alpha. The effects that IL-1 alpha, IL-1 beta,
TGF-beta, TNF-alpha, and IL-6 have on hypoxia-induced Epo production may
provide new insights into the signal transduction pathway by which hypoxia
leads to changes in gene expression. In addition, the effects of these
inflammatory cytokines on hypoxia- induced Epo production in vitro suggest
that in various inflammatory disorders these cytokines may affect Epo
production in vivo and may play a significant role in the pathogenesis of
the anemia of chronic disease.
Volume 79,
Issue 8,
pp. 1987-1994,
04/15/1992
Copyright © 1992 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. L. M. de Francisco, P. Stenvinkel, and S. Vaulont
Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness
NDT Plus,
January 1, 2009;
2(suppl_1):
i18 - i26.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Hassan
Anemia in the Critically Ill Patient
Journal of Pharmacy Practice,
December 1, 2008;
21(6):
405 - 410.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. Bergamaschi, K. Markopoulos, R. Albertini, A. Di Sabatino, F. Biagi, R. Ciccocioppo, E. Arbustini, and G. R. Corazza
Anemia of chronic disease and defective erythropoietin production in patients with celiac disease
Haematologica,
December 1, 2008;
93(12):
1785 - 1791.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W. Adamson
The Anemia of Inflammation/Malignancy: Mechanisms and Management
Hematology,
January 1, 2008;
2008(1):
159 - 165.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Ryan, J. K. Carroll, E. P. Ryan, K. M. Mustian, K. Fiscella, and G. R. Morrow
Mechanisms of Cancer-Related Fatigue
Oncologist,
May 1, 2007;
12(suppl_1):
22 - 34.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. E. Jie, M. C. Verhaar, M.-J. M. Cramer, K. van der Putten, C. A. J. M. Gaillard, P. A. Doevendans, H. A. Koomans, J. A. Joles, and B. Braam
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors
Am J Physiol Renal Physiol,
November 1, 2006;
291(5):
F932 - F944.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Theurl, V. Mattle, M. Seifert, M. Mariani, C. Marth, and G. Weiss
Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease
Blood,
May 15, 2006;
107(10):
4142 - 4148.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S Giannouli, M Voulgarelis, P D Ziakas, and A G Tzioufas
Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment
Ann Rheum Dis,
February 1, 2006;
65(2):
144 - 148.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Opasich, M. Cazzola, L. Scelsi, S. De Feo, E. Bosimini, R. Lagioia, O. Febo, R. Ferrari, A. Fucili, R. Moratti, et al.
Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure
Eur. Heart J.,
November 1, 2005;
26(21):
2232 - 2237.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E Cusick, J. M Tielsch, M. Ramsan, J. K Jape, S. Sazawal, R. E Black, and R. J Stoltzfus
Short-term effects of vitamin A and antimalarial treatment on erythropoiesis in severely anemic Zanzibari preschool children
Am. J. Clinical Nutrition,
August 1, 2005;
82(2):
406 - 412.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Horiguchi, E. Oguma, and F. Kayama
The effects of iron deficiency on estradiol-induced suppression of erythropoietin induction in rats: implications of pregnancy-related anemia
Blood,
July 1, 2005;
106(1):
67 - 74.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B J M Ripley, B Goncalves, D A Isenberg, D S Latchman, and A Rahman
Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia
Ann Rheum Dis,
June 1, 2005;
64(6):
849 - 853.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. N Pierce and D. F Larson
Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device
Perfusion,
March 1, 2005;
20(2):
83 - 90.
[Abstract]
[PDF]
|
|
|
|
|
|
|
Y. Nakano, S. Imagawa, K. Matsumoto, C. Stockmann, N. Obara, N. Suzuki, T. Doi, T. Kodama, S. Takahashi, T. Nagasawa, et al.
Oral administration of K-11706 inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity, and restores indicators in an in vivo mouse model of anemia of chronic disease
Blood,
December 15, 2004;
104(13):
4300 - 4307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C Gasche, M C E Lomer, I Cavill, and G Weiss
Iron, anaemia, and inflammatory bowel diseases
Gut,
August 1, 2004;
53(8):
1190 - 1197.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Fandrey
Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 2004;
286(6):
R977 - R988.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tsantes, S. Tassiopoulos, S. I. Papadhimitriou, S. Bonovas, L. Kavalierou, G. Vaiopoulos, and I. Meletis
Suboptimal Erythropoietic Response to Hypoxemia in Idiopathic Pulmonary Fibrosis
Chest,
August 1, 2003;
124(2):
548 - 553.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. C. Aird
The Hematologic System as a Marker of Organ Dysfunction in Sepsis
Mayo Clin. Proc.,
July 1, 2003;
78(7):
869 - 881.
[Abstract]
[PDF]
|
|
|
|
|
|
|
V. A. Shatrov, V. V. Sumbayev, J. Zhou, and B. Brune
Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1{alpha} (HIF-1{alpha}) accumulation via redox-dependent mechanisms
Blood,
June 15, 2003;
101(12):
4847 - 4849.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Pawlak, M. Koda, S. Pawlak, S. Wolczynski, and W. Buczko
Contribution of quinolinic acid in the development of anemia in renal insufficiency
Am J Physiol Renal Physiol,
April 1, 2003;
284(4):
F693 - F700.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Nussenblatt, G. Mukasa, A. Metzger, G. Ndeezi, E. Garrett, and R. D. Semba
Anemia and Interleukin-10, Tumor Necrosis Factor Alpha, and Erythropoietin Levels among Children with Acute, Uncomplicated Plasmodium falciparum Malaria
Clin. Vaccine Immunol.,
November 1, 2001;
8(6):
1164 - 1170.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. Mazzeo, D. Donovan, M. Fleshner, G. E. Butterfield, S. Zamudio, E. E. Wolfel, and L. G. Moore
Interleukin-6 response to exercise and high-altitude exposure: influence of alpha -adrenergic blockade
J Appl Physiol,
November 1, 2001;
91(5):
2143 - 2149.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. L. Greenberg, V. Gordeuk, S. Issaragrisil, N. Siritanaratkul, S. Fucharoen, and R. C. Ribeiro
Major Hematologic Diseases in the Developing World-- New Aspects of Diagnosis and Management of Thalassemia, Malarial Anemia, and Acute Leukemia
Hematology,
January 1, 2001;
2001(1):
479 - 498.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. T. Goodnough, B. Skikne, and C. Brugnara
Erythropoietin, iron, and erythropoiesis
Blood,
August 1, 2000;
96(3):
823 - 833.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Voulgarelis, S. I G Kokori, J. P A Ioannidis, A. G Tzioufas, D. Kyriaki, and H. M Moutsopoulos
Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin
Ann Rheum Dis,
March 1, 2000;
59(3):
217 - 222.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
B. L. Ebert and H. F. Bunn
Regulation of the Erythropoietin Gene
Blood,
September 15, 1999;
94(6):
1864 - 1877.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Hellwig-Burgel, K. Rutkowski, E. Metzen, J. Fandrey, and W. Jelkmann
Interleukin-1beta and Tumor Necrosis Factor-alpha Stimulate DNA Binding of Hypoxia-Inducible Factor-1
Blood,
September 1, 1999;
94(5):
1561 - 1567.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Frey, T. Duke, and S. B Horton
Nucleated red blood cells after cardiopulmonary bypass in infants and children: is there a relationship to the systemic inflammatory response syndrome?
Perfusion,
May 1, 1999;
14(3):
173 - 180.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. Corazza, Y. Beguin, P. Bergmann, M. Andre, A. Ferster, C. Devalck, P. Fondu, M. Buyse, and E. Sariban
Anemia in Children With Cancer Is Associated With Decreased Erythropoietic Activity and Not With Inadequate Erythropoietin Production
Blood,
September 1, 1998;
92(5):
1793 - 1798.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. H. Henry
Supplemental Iron: A Key to Optimizing the Response of Cancer-Related Anemia to rHuEPO?
Oncologist,
August 1, 1998;
3(4):
275 - 278.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Cazzola, R. Guarnone, P. Cerani, E. Centenara, A. Rovati, and Y. Beguin
Red Blood Cell Precursor Mass as an Independent Determinant of Serum Erythropoietin Level
Blood,
March 15, 1998;
91(6):
2139 - 2145.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cazzola, F. Mercuriali, and C. Brugnara
Use of Recombinant Human Erythropoietin Outside the Setting of Uremia
Blood,
June 15, 1997;
89(12):
4248 - 4267.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Schreiber, S. Howaldt, M. Schnoor, S. Nikolaus, J. Bauditz, C. Gasche, H. Lochs, and A. Raedler
Recombinant Erythropoietin for the Treatment of Anemia in Inflammatory Bowel Disease
N. Engl. J. Med.,
March 7, 1996;
334(10):
619 - 624.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Kuter
Thrombopoietin: Biology and Clinical Applications
Oncologist,
February 1, 1996;
1(1):
98 - 106.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
